Development of a functional outcome measure for riboflavin transporter deficiency

被引:1
|
作者
Fennessy, Jack R. [1 ]
Donlevy, Gabrielle A. [1 ,2 ]
Mckay, Marnee J. [1 ]
Burns, Joshua [1 ,2 ]
Cornett, Kayla M. D. [1 ,2 ]
Menezes, Manoj P. [3 ,4 ,5 ]
机构
[1] Univ Sydney, Fac Med & Hlth, Sch Hlth Sci, Sydney, NSW, Australia
[2] Sydney Childrens Hosp Network, Paediat Gait Anal Serv New South Wales, Westmead, NSW, Australia
[3] Univ Sydney, Westmead Clin Sch, Fac Med & Hlth, Childrens Hosp, Sydney, NSW, Australia
[4] Childrens Hosp Westmead, TY Nelson Dept Neurol & Neurosurg, Sydney, NSW, Australia
[5] Childrens Hosp Westmead, TY Nelson Dept Neurol & Neurosurg, Westmead, NSW 2145, Australia
关键词
clinical outcome assessment; clinical trials; endpoint; performance outcome measure; riboflavin transporter deficiency; MARIE-TOOTH DISEASE; REFERENCE VALUES; MUTATIONS; VARIABILITY; VALIDATION; SCALE;
D O I
10.1111/jns.12619
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and AimsRiboflavin transporter deficiency (RTD) is a progressive inherited neuropathy of childhood onset, characterised clinically by pontobulbar palsy, sensory ataxia, sensorineural deafness, muscle weakness, optic atrophy and respiratory failure. A robust and responsive functional outcome measure is essential for future clinical trials of disease-modifying therapies including genetic therapies. The Charcot-Marie-Tooth disease Pediatric Scale (CMTPedS) is a well-validated outcome measure for CMT and related neuropathies, and might have utility for measuring disease progression in individuals with RTD. However, the CMTPedS requires modifications to account for phenotypic differences between children with CMT and RTD. The aim of this study was to develop a functional outcome measure based on the CMTPedS for specific use in individuals with RTD.MethodsThe CMTPedS data collected over the last 10 years in individuals with RTD attending the Peripheral Neuropathy Management Clinic at the Children's Hospital at Westmead (Sydney, Australia) were reviewed to evaluate each item within the CMTPedS. A literature review of articles published until September 2021 for functional outcome measures generated an item pool for pilot testing. The results of this pilot testing, alongside analysis of existing CMTPedS item scores in the RTD cohort, informed the modification of the CMTPedS.ResultsCMTPedS data were reviewed for eight individuals over the past 10 years. Two items were identified as requiring modification or removal and additional items of proximal strength and function needed to be considered. Six studies were identified in the literature review, and five items were selected for pilot testing. 'Shoulder internal rotation' and the '30-s sit to stand test' were added as proximal measures of strength and function. The composite balance item comprising nine tasks in the CMTPedS showed a ceiling effect and was replaced with the single 'Feet apart on a line eyes open' balance item. 'Pinprick sensation' was removed due to a floor effect.InterpretationThis study provides preliminary evidence that the Riboflavin Transporter Deficiency Pediatric Scale (RTDPedS) is a functional outcome measure covering strength, upper and lower limb function, balance and mobility for individuals with RTD to assess disease severity and progression in clinical trials and cohort studies.
引用
收藏
页码:185 / 192
页数:8
相关论文
共 50 条
  • [21] Identification and Functional Characterization of Rat Riboflavin Transporter 2
    Yamamoto, Syunsuke
    Inoue, Katsuhisa
    Ohta, Kin-ya
    Fukatsu, Rui
    Maeda, Jun-ya
    Yoshida, Yukihiro
    Yuasa, Hiroaki
    JOURNAL OF BIOCHEMISTRY, 2009, 145 (04): : 437 - 443
  • [22] URINARY RIBOFLAVIN EXCRETION AFTER A LOAD TEST IN RURAL CHINA AS A MEASURE OF POSSIBLE RIBOFLAVIN DEFICIENCY
    BRUN, TA
    CHEN, J
    CAMPBELL, TC
    BOREHAM, J
    FENG, Z
    PARPIA, B
    SHEN, TF
    LI, M
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 1990, 44 (03) : 195 - 206
  • [23] Riboflavin transporter deficiency diagnosed 30 years after onset of symptoms
    van der Kooi, A.
    Jaeger, B.
    van Spaendonck, K.
    Bosch, A.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S201 - S201
  • [24] Riboflavin transporter deficiency, the search for the undiagnosed: a retrospective data mining study
    Jaeger, B.
    van Konijnenburg, E. Hoytema
    Groenveld, M. A.
    Langeveld, M.
    Wolf, N. I.
    Bosch, A. M.
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [25] The First Case of Riboflavin Transporter Deficiency insub-Saharan Africa
    Chaya, Shaakira
    Zampoli, Marco
    Gray, Diane
    Booth, Jane
    Riordan, Gillian
    Ndondo, Alvin
    Fieggen, Karen
    Rusch, Jody
    van der Watt, George
    Pillay, Komala
    van der Westhuizen, Francois
    Menezes, Manoj
    Wilmshurst, Jo
    SEMINARS IN PEDIATRIC NEUROLOGY, 2018, 26 : 10 - 14
  • [26] Mitochondrial and Peroxisomal Alterations Contribute to Energy Dysmetabolism in Riboflavin Transporter Deficiency
    Colasuonno, Fiorella
    Niceforo, Alessia
    Marioli, Chiara
    Fracassi, Anna
    Stregapede, Fabrizia
    Massey, Keith
    Tartaglia, Marco
    Bertini, Enrico
    Compagnucci, Claudia
    Moreno, Sandra
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
  • [27] Role of Otolaryngologists in the Treatment of Patients With Riboflavin Transporter Deficiency: A Case Report
    Alasqah, Mohammad I.
    Aldriweesh, Bshair
    Alshareef, Waleed A.
    Alhashem, Muataz H.
    Alammar, Ahmad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)
  • [28] An update on the genetics, clinical presentation, and pathomechanisms of human riboflavin transporter deficiency
    O'Callaghan, Benjamin
    Bosch, Annet M.
    Houlden, Henry
    JOURNAL OF INHERITED METABOLIC DISEASE, 2019, 42 (04) : 598 - 607
  • [29] ACCELERATED DEVELOPMENT OF RIBOFLAVIN DEFICIENCY BY TREATMENT WITH CHLORPROMAZINE
    PELLICCIONE, N
    PINTO, J
    HUANG, YP
    RIVLIN, RS
    BIOCHEMICAL PHARMACOLOGY, 1983, 32 (19) : 2949 - 2953
  • [30] Toddlers with limb deficiency: Conceptual basis and initial application of a functional status outcome measure
    Pruitt, SD
    Seid, M
    Varni, JW
    Setoguchi, Y
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1999, 80 (07): : 819 - 824